BioSpace News Archive

Bioventus has entered into a definitive agreement to divest its next generation bone morphogenetic protein development program to a new company formed by Viscogliosi Brothers, LLC (VB), a private equity investment firm focused on developing innovative neuromusculoskeletal technologies.

Axol Bioscience, launch their Human iPSC-derived Atrial Cardiomyocytes for the discovery and development of novel treatments and advancing our understanding of cardiovascular disease.

Habitat will implement award-winning aging-in-place research by Johns Hopkins School of Nursing in five communities in the United States

Naya Clinics now offers a unique pet therapy program for families and individuals in the Cincinnati/Northern Kentucky metropolitan area.

Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, announced today the Food and Drug Administration (FDA) clearance of its BF-MP190F, a fully rotatable, ultra-slim bronchoscope featuring an optimal ratio of working channel to outer diameter size, compatible with the radial endobronchial ultrasound (EBUS) probe and an array of sampling devices to expand access to smaller, more distal airways.

The Football Writers Association of America (FWAA) and the National Foundation for Infectious Diseases (NFID) announced a new partnership to present the 2018 Outland Trophy as part of a public awareness campaign focused on the importance of influenza (flu) prevention during the 2018-2019 flu season.

MetroHealth and Medical Mutual are first to go live with new software solution; increasing collaboration and accelerating processes while reducing costs

New board officers, Chairs of Subspecialty Divisions, and Subspecialty Division Members for The American Board of Obstetrics and Gynecology (ABOG) officially started their new appointments on July 1.

A signaling pathway that helps promote normal cell growth worsens a form of leukemia by taking control of another pathway better known for protecting cells from biological stress, a new study shows.

For the first-time, researchers at IMBA - Institute of Molecular Biotechnology of the Austrian Academy of Sciences - develop organoids, that mimic the onset of brain cancer.